LatinNews Regional Monitor: Mexico - 16 September 2019

* Mexico’s public service secretariat (SFP), the federal oversight body, has sanctioned two local pharmaceutical companies for failing to comply with a law on acquisitions after allegedly falsifying information in order to participate in tenders for public contracts. The companies Lomedic, SA de CV and Laboratorios Solfrán, SA were each fined M$1.51m (US$78m) and disqualified from participating in future public bidding processes for two years and six months. The companies are owned by Carlos Lomelí, a former federal government delegate to the western state of Jalisco who was forced to resign in July following allegations first made by anti-corruption NGO Mexicanos Contra la Corrupción y la Impunidad (MCCI) in May that Lomelí was involved in corruption. MCCI investigations have linked Lomelí to nine pharmaceutical companies which have been awarded government contracts worth over M$164m (US$8.6m) and Lomelí was accused of a conflict of interest.

End of preview - This article contains approximately 149 words.

Subscribers: Log in now to read the full article

Not a Subscriber?

Choose from one of the following options

• Subscribe
• Sign up for a one-time, 14-day trial